Paper Details

  1. Home
  2. Paper Details

Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis.

Author: JiangYongqing, LiFeng, LuanLili, YueBei

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Traditional Chinese medicine (TCM) combined with Western medicine significantly improved treatment outcomes for COVID-19 patients compared to Western medicine alone. A meta-analysis of 8 studies involving 750 patients found that TCM improved overall effective rate, fever symptom disappearance rate, fatigue symptom disappearance rate, cough symptom disappearance rate, and sputum production reduction.
Paper Details　
Original Abstract of the Article :
BACKGROUND: This review aims to evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19). METHODS: Five databases were searched through July 7, 2020. Randomized controlled trials investigating the efficacy of TCM ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322509/

データ提供：米国国立医学図書館（NLM）

Traditional Chinese Medicine: A Potential Ally in the Fight Against COVID-19

The field of infectious diseases is grappling with the global pandemic of COVID-19. This systematic review and meta-analysis explores the potential role of traditional Chinese medicine (TCM) as an adjunctive treatment for COVID-19. The authors reviewed eight randomized controlled trials that investigated the efficacy of TCM in combination with Western medicine for treating COVID-19 patients. The meta-analysis pooled data from these trials, providing a comprehensive overview of the evidence for the effectiveness of TCM in this setting. This study is like a journey through a medicinal garden, where we explore the diverse remedies offered by TCM and their potential applications in modern medicine.

TCM's Potential in COVID-19 Treatment

The meta-analysis found that the integration of TCM with Western medicine significantly improved the overall effective rate, as well as the disappearance rate of symptoms like fever, fatigue, cough, and sputum production. This finding is like a refreshing breeze in the desert, offering hope for improving patient outcomes and alleviating the suffering caused by COVID-19. The research suggests that TCM may play a supportive role in COVID-19 treatment, potentially helping to enhance the effectiveness of Western medicine therapies.

The Promise of TCM: Exploring Its Potential

The study highlights the need for further research to evaluate the efficacy and safety of TCM in treating COVID-19. This is like venturing deeper into the desert, searching for new and promising resources. The authors emphasize the importance of conducting large-scale, high-quality clinical trials to provide more definitive evidence for the effectiveness of TCM in this context.

Dr.Camel's Conclusion

This systematic review and meta-analysis offers a promising glimpse into the potential of TCM as an adjunctive treatment for COVID-19. The findings provide preliminary evidence for the effectiveness of TCM in this setting, but further research is needed to confirm these results. As a researcher, I am intrigued by the possibilities offered by TCM and its potential to complement Western medicine in treating infectious diseases.

Date :
  1. Date Completed 2021-08-23
  2. Date Revised 2023-09-20
Further Info :

Pubmed ID

34397691

DOI: Digital Object Identifier

PMC8322509

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.